
newscancer clinical trialsfederal sponsorship
Divergent Roles of Federal and Industry Sponsors in US Cancer Clinical Trials: Insights from 2008 to 2024
By MedXY|Aug 22, 2026
This study quantifies how federal and industry sponsorship differ in US cancer clinical trials, highlighting complementary focuses: industry emphasizes single-agent drug therapies, while federal trials prioritize multimodality regimens, rar
